128 related articles for article (PubMed ID: 34489516)
1. Nurse-led, telephone-based follow-up after acute coronary syndrome yields improved risk factors after 36 months: the randomized controlled NAILED-ACS trial.
Henriksson R; Huber D; Mooe T
Sci Rep; 2021 Sep; 11(1):17693. PubMed ID: 34489516
[TBL] [Abstract][Full Text] [Related]
2. Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial.
Huber D; Henriksson R; Jakobsson S; Mooe T
PLoS One; 2017; 12(9):e0183963. PubMed ID: 28886083
[TBL] [Abstract][Full Text] [Related]
3. Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial.
Ögren J; Irewall AL; Söderström L; Mooe T
BMC Neurol; 2018 Sep; 18(1):153. PubMed ID: 30241499
[TBL] [Abstract][Full Text] [Related]
4. Nurse-Led, Telephone-Based, Secondary Preventive Follow-Up after Stroke or Transient Ischemic Attack Improves Blood Pressure and LDL Cholesterol: Results from the First 12 Months of the Randomized, Controlled NAILED Stroke Risk Factor Trial.
Irewall AL; Ögren J; Bergström L; Laurell K; Söderström L; Mooe T
PLoS One; 2015; 10(10):e0139997. PubMed ID: 26474055
[TBL] [Abstract][Full Text] [Related]
5. Nurse-led, telephone-based secondary preventive follow-up benefits stroke/TIA patients with low education: a randomized controlled trial sub-study.
Irewall AL; Ögren J; Bergström L; Laurell K; Söderström L; Mooe T
Trials; 2019 Jan; 20(1):52. PubMed ID: 30646948
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study.
Jakobsson S; Irewall AL; Bjorklund F; Mooe T
BMC Cardiovasc Disord; 2015 Oct; 15():125. PubMed ID: 26466804
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial.
Jakobsson S; Huber D; Björklund F; Mooe T
BMC Cardiovasc Disord; 2016 Apr; 16():77. PubMed ID: 27129980
[TBL] [Abstract][Full Text] [Related]
8. Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database.
Bentzel S; Ljungman C; Hjerpe P; Schiöler L; Manhem K; Bengtsson Boström K; Kahan T; Mourtzinis G
Eur J Prev Cardiol; 2024 May; 31(7):812-821. PubMed ID: 38135289
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): participation rate, reasons for non-participation and 1-year survival.
Huber D; Henriksson R; Jakobsson S; Stenfors N; Mooe T
Trials; 2016 Feb; 17():85. PubMed ID: 26876722
[TBL] [Abstract][Full Text] [Related]
10. Statin treatment after acute coronary syndrome: Adherence and reasons for non-adherence in a randomized controlled intervention trial.
Daniel H; Christian W; Robin H; Lars S; Thomas M
Sci Rep; 2019 Aug; 9(1):12079. PubMed ID: 31427637
[TBL] [Abstract][Full Text] [Related]
11. The Nurse-Based Age Independent Intervention to Limit Evolution of Disease After Acute Coronary Syndrome (NAILED ACS) Risk Factor Trial: Protocol for a Randomized Controlled Trial.
Mooe T; Björklund F; Graipe A; Huber D; Jakobsson S; Kajermo U; Strömvall A; Ulvenstam A
JMIR Res Protoc; 2014 Aug; 3(3):e42. PubMed ID: 25131960
[TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.
Kristensen MS; Green A; Nybo M; Hede SM; Mikkelsen KH; Gislason G; Larsen ML; Ersbøll AK
BMC Cardiovasc Disord; 2020 Jul; 20(1):336. PubMed ID: 32660429
[TBL] [Abstract][Full Text] [Related]
13. Surveillance and treatment of dyslipidemia in the post-infarct patient: can a nurse-led management approach make a difference?
Lapointe F; Lepage S; Larrivée L; Maheux P
Can J Cardiol; 2006 Jul; 22(9):761-7. PubMed ID: 16835670
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention.
Zhang W; Ji F; Yu X; Wang X
Medicine (Baltimore); 2017 Jan; 96(1):e5469. PubMed ID: 28072688
[TBL] [Abstract][Full Text] [Related]
15. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
[TBL] [Abstract][Full Text] [Related]
16. Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS).
Koskinas KC; Windecker S; Pedrazzini G; Mueller C; Cook S; Matter CM; Muller O; Häner J; Gencer B; Crljenica C; Amini P; Deckarm O; Iglesias JF; Räber L; Heg D; Mach F
J Am Coll Cardiol; 2019 Nov; 74(20):2452-2462. PubMed ID: 31479722
[TBL] [Abstract][Full Text] [Related]
17. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
Lee JK; Grace KA; Taylor AJ
JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical impact of decreased low-density lipoprotein cholesterol level at baseline on the long-term prognosis in patients with acute coronary syndrome.
Nakahashi T; Tada H; Sakata K; Yakuta Y; Tanaka Y; Nomura A; Gamou T; Terai H; Horita Y; Ikeda M; Namura M; Takamura M; Hayashi K; Yamagishi M; Kawashiri MA
Heart Vessels; 2018 Jul; 33(7):695-705. PubMed ID: 29288404
[TBL] [Abstract][Full Text] [Related]
19. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N
J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.
Zanchetti A; Liu L; Mancia G; Parati G; Grassi G; Stramba-Badiale M; Silani V; Bilo G; Corrao G; Zambon A; Scotti L; Zhang X; Wang H; Zhang Y; Zhang X; Guan TR; Berge E; Redon J; Narkiewicz K; Dominiczak A; Nilsson P; Viigimaa M; Laurent S; Agabiti-Rosei E; Wu Z; Zhu D; Rodicio JL; Ruilope LM; Martell-Claros N; Pinto F; Schmieder RE; Burnier M; Banach M; Cifkova R; Farsang C; Konradi A; Lazareva I; Sirenko Y; Dorobantu M; Postadzhiyan A; Accetto R; Jelakovic B; Lovic D; Manolis AJ; Stylianou P; Erdine S; Dicker D; Wei G; Xu C; Xie H; Coca A; O'Brien J; Ford G
J Hypertens; 2014 Sep; 32(9):1888-97. PubMed ID: 24979303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
